General Discussion
In reply to the discussion: Whoa! My Lynparza cost right at $15,000 a month. [View all]TommyT139
(1,597 posts)I did a quick search, and Lynparza is a drug sold by Canadian pharmacies to US patients. Still horrendously expensive, but less than one-third the price.
https://pharmagiant.com/product/lynparza/ (Just one example; do a search for other companies' prices.)
It is also listed on the Medicaid formulary for Massachusetts, which implemented the Medicaid expansion (unlike Texas, if I understand correctly?).
On this page, do a find word search:
https://mhdl.pharmacy.services.conduent.com/MHDL/pubtheradetail.do?id=1207&drugId=4783
That shows the diagnostic requirements for pre-authorization, just FYI.
However, the fact that you have already started the drug, and it is time-limited (2 years?), could give you the best argument to keep getting it. I didn't look at the package insert -- and hate to raise the possibility -- but if cessation of the drug comes with any negative "rebound," that is yet more in your favor, especially in any discussions with AstraZeneca.
If you haven't already, get to know the medical social worker on your oncology team. They may also be called case manager, or navigator, something like that, depending on exact role. Their job is to help you with things like this, including strategizing for the possibility of losing your coverage. Get in touch with them sooner rather than later.
Advice over for now; here beginneth a brief rant.
It is maddening, the disparities even between states here in the US. In Mass., there is no minimum time for residency to get on MassHealth (Medicaid), if one qualifies. I don't know if the income cutoffs are higher than TX, although I bet they are.
The coupons-only-for-privately-insured-patients is an outcome of the system that Joe and Kamala were trying to change: the prohibition of the govt negotiating as the biggest "customer" of pharmaceutical companies. For all the billions that Doge claimed to want to save, lots of $ could have been saved by changing this. Except it would have decreased profits of Big Pharma...despite so much of the research being publicly funded. (Well, I guess that last part won't be a problem any more.) The drugs on their 15/year lists were among the most expensive, needed by the most Americans.
Anyway, I hope these ideas give you a bit of hope, and possibly some new tactics. Sorry you need to come here for advice on this, but glad you did, and that DU comes through as best we can.
Edit history
Recommendations
1 members have recommended this reply (displayed in chronological order):